These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34504627)

  • 1. Decreased Serum NCAM Levels Associated with Cognitive Impairment in Vascular Dementia.
    Zhao J; Lu W; Li J; Liu L; Zhao X
    Dis Markers; 2021; 2021():2792884. PubMed ID: 34504627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Levels of Serum IL-34 Associated with Cognitive Impairment in Vascular Dementia.
    Wang Y; Lu W; Ning W; Chen Y; Li L
    Biomed Res Int; 2021; 2021():6793860. PubMed ID: 34095310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Levels of Serum Neuregulin 1 Associated with Cognitive Impairment in Vascular Dementia.
    Wang X; Zhang F; Ma W; Feng D; Zhang J; Xu J
    Biomed Res Int; 2020; 2020():6683747. PubMed ID: 33274218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia.
    Ma W; Zhang J; Xu J; Feng D; Wang X; Zhang F
    Dis Markers; 2020; 2020():6612871. PubMed ID: 33204362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship between Serum Amyloid A Level and Cognitive Dysfunction in Patients with Vascular Dementia: Preliminary Findings.
    Xu M; He XY; Huang P
    Biomed Res Int; 2021; 2021():6676144. PubMed ID: 33644229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum NPTX2 and cognitive function in patients with vascular dementia.
    Shao K; Shan S; Ru W; Ma C
    Brain Behav; 2020 Oct; 10(10):e01779. PubMed ID: 32748547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum FAM19A5 with Cognitive Impairment in Vascular Dementia.
    Li J; Li S; Song Y; Zhou W; Zhu X; Xu S; Ma Y; Zhu C
    Dis Markers; 2020; 2020():8895900. PubMed ID: 32831973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum NCAM levels and cognitive deficits in first episode schizophrenia patients versus health controls.
    An H; Zhou L; Yu Y; Fan H; Fan F; Tan S; Wang Z; Z B; Shi J; Yang F; Zhang X; Tan Y; Huang XF
    Schizophr Res; 2018 Feb; 192():457-458. PubMed ID: 28624138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
    Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
    Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia.
    Watanabe T; Koba S; Kawamura M; Itokawa M; Idei T; Nakagawa Y; Iguchi T; Katagiri T
    Metabolism; 2004 Apr; 53(4):476-82. PubMed ID: 15045695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CCL21 as a Potential Biomarker for Cognitive Impairment in Spinal Cord Injury.
    Chen Y; Liang L; Cao S; Hou G; Zhang Q; Ma H; Shi B
    Biomed Res Int; 2020; 2020():6692802. PubMed ID: 33376730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher serum β2-microglobulin is a predictive biomarker for cognitive impairment in spinal cord injury.
    Cui Z; Wang S; Hao Y; Chen Y
    PeerJ; 2023; 11():e15372. PubMed ID: 37193029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum insulin-like growth factor-I (IGF-I) level is associated with increased risk of vascular dementia.
    Quinlan P; Horvath A; Nordlund A; Wallin A; Svensson J
    Psychoneuroendocrinology; 2017 Dec; 86():169-175. PubMed ID: 28963885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of serum Kallikrein-8 with cognitive function in vascular dementia.
    Li J; Li SL; Song YH; Li ZP; Wang N; Zhang GH; Zhu CL
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1997-2002. PubMed ID: 33660811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Serum Neuropeptide FF Levels Are Associated with Cognitive Decline in Patients with Spinal Cord Injury.
    Sun S; Sun S; Meng Y; Shi B; Chen Y
    Dis Markers; 2021; 2021():4549049. PubMed ID: 34804262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Changes in Cognitive Function in Early Recovery Phase of the Stroke.
    Dharmasaroja PA
    J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106027. PubMed ID: 34388404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia.
    Ban Y; Watanabe T; Miyazaki A; Nakano Y; Tobe T; Idei T; Iguchi T; Ban Y; Katagiri T
    Atherosclerosis; 2007 Nov; 195(1):153-9. PubMed ID: 17049533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors of vascular dementia in Thai stroke patients.
    Dharmasaroja PA; Limwongse C; Charernboon T
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104878. PubMed ID: 32417242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation study of Framingham risk score and vascular dementia: An observational study.
    Li SS; Zheng J; Mei B; Wang HY; Zheng M; Zheng K
    Medicine (Baltimore); 2017 Dec; 96(50):e8387. PubMed ID: 29390252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neural cell adhesion molecule (NCAM) present in the cerebrospinal fluid of multiple sclerosis patients is unsialylated.
    Massaro AR; De Pascalis D; Carnevale A; Carbone G
    Eur Rev Med Pharmacol Sci; 2009; 13(5):397-9. PubMed ID: 19961048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.